U.S. Court Blocks Alternative to AstraZeneca’s Nexium

An appeals court in the U.S. has temporarily blocked South Korean Hanmi Pharmaceutical from launching an alternative to AstraZeneca’s Nexium. Hanmi now has a week to respond to the court’s action.
Pharma Times